v3.25.2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating activities        
Net loss $ (1,570,976) $ (1,267,218) $ (2,877,154) $ (2,847,038)
Adjustments to reconcile net loss to net cash used in operating activities:        
Stock-based compensation expense 104,253 126,578 188,637 380,607
Non-cash interest expense 124,658 124,657 247,945 249,315
Non-cash operating lease expense     38,294  
Change in operating assets and liabilities:        
Accounts receivable     (485,070) (1,329,932)
Prepaid expenses and other assets     571,766 521,961
Inventories     (196,791) (62,925)
Accounts payable and accrued expenses     1,247,099 586,220
Accrued compensation     (258,511) (898,213)
Operating lease liabilities     (38,742)  
Net cash used in operating activities     (1,562,527) (3,400,005)
Financing activities        
Proceeds from amendment and exercise of Series B Warrants, net of issuance costs       1,546,497
Proceeds from the issuance of common stock pursuant to the ESPP     24,999  
Net cash provided by financing activities     24,999 7,838,415
Net (decrease) increase in cash and cash equivalents     (1,537,528) 4,438,410
Cash and cash equivalents at beginning of period     13,596,600 4,739,426
Cash and cash equivalents at end of period $ 12,059,072 $ 9,177,836 $ 12,059,072 9,177,836
Supplemental disclosure of non-cash investing and financing activities        
Warrant amendment costs included in accounts payable and accrued expenses       8,190
February 2024 Offering [Member]        
Financing activities        
Proceeds from Issuance Initial Public Offering       6,718,211
Payment of Offering costs       $ (426,293)